Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Coherus BioSciences will see its workforce shrink once again as the result of the recently agreed sale of its Neulasta ...

London-headquartered Accord is one of the largest suppliers of chemotherapy products in Europe and is a wholly-owned subsidiary of India's Intas Pharma, which has annual revenues of around $3.4 ...

Pharmerging Market Pharmerging Market Poised for Rapid Growth Amid Rising Healthcare Demands US, NY, UNITED STATES, March 15, 2025 /EIN ...

New Delhi: Mylan Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

PM Internship Scheme 2025 Registration: The registration for the Prime Minister’s Internship Scheme 2025 will close on March 12, 2025. Launched by the Ministry of Corporate Affairs, this initiative ...

With 28 pioneering speakers from large pharma, innovative biotech and KOLs of academia who are ready to discuss the full and comprehensive range of RNAi drugs from discovery to development and ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. The White House withdrew President Donald Trump's nomination of former ...

Healthcare & Pharmaceuticalscategory· March 10, 2025 India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million India's Sun Pharmaceutical Industries said on Monday it will acquire ...